GLP-1 weight loss drugs are no longer just a healthcare story—they are reshaping how consumers eat, snack, and spend on food. As appetite suppression reduces cravings, traditional snack demand is softening while interest grows in portion-controlled and nutrient-dense options. This piece examines how the food and beverage industry is being disrupted and where brands must evolve to stay... https://www.indigrowth.com/weight-loss-pills-are-eating-snack-sales/